How To Get the Most Value From Your Costco Membership in 2025
Do you have a Costco membership? If so, you're probably well aware of the bulk prices. But are you taking advantage of all your membership's benefits? If not, you should be.
Read More:
Find Out:
Here's how to get the most out of your Costco membership in 2025.
You can save money by shopping online via Costco Direct. You can get instant savings on everyday items, many of which are already marked down.
Some big-ticket items — like patio furniture, appliances and electronics — have surprisingly high markdowns. Some items are as much as $400 off. As a Costco member, you can redeem discounts from tagged products twice.
Costco Next offers exclusive discounts on online products. Know that you aren't buying directly from Costco, but rather from a third-party supplier. Still, you can get some Costco prices on sporting equipment, apparel, skincare products and so much more.
As a Costco member, you could benefit from the warehouse club's Prescription Program. You could save up to 80% on select medications. You can also compare medication prices to ensure you're getting the best deal.
Discover Next:
Costco members can get discounts on eyewear through Costco Optical, even if you don't have vision insurance. This is the case for contact lenses, prescription glasses and nonprescription glasses. Costco also accepts most major vision insurance plans.
As part of its focus on health and wellness, Costco also offers free hearing tests, free follow-up appointments, and free hearing aid cleanings and checkups. You can also get free loss and damage coverage on certain hearing-related devices. As for the devices themselves, Kirkland Signature brand hearing aids are potentially cheaper than other name-brand options.
Do you have auto and home insurance? If you use your Costco membership, you could potentially get a better rate, especially if you bundle multiple vehicles on one policy.
For frequent travelers, Costco Travel is another great way to maximize that membership. You can shop around for the best prices on hotels, planes, cruises, rental cars and vacation packages. You'll need to reside in the United States, though.
According to The Krazy Coupon Lady, Costco's gasoline prices are about $0.11 cheaper per gallon than other leading brands. That might not seem like much, but if you live nearby and are filling up anyway, why not save?
You probably know that Costco sells gift cards, but did you know you could actually save money by purchasing gift cards from the warehouse club?
For example, a gift card to Spafinder valued at $100 costs just $79.99 at Costco. A four-pack of Domino's gift cards valued at $25 each (or $100 total) also costs $79.99.
As an Executive or Gold Star member, you can get additional benefits. For example, the Executive card comes with a 2% reward on eligible Costco travel and regular purchases (up to $1,250 annually).
With the Costco Anywhere Visa® Card, you can also earn cash back:
Up to 5% on Costco gas
4% on other gas and EV charging
3% on restaurants and eligible travel
2% on all other Costco purchases
1% on all other purchases
More From GOBankingRatesHow Paychecks Would Look in Each State If Trump Dropped Federal Income Tax10 Cars That Outlast the Average Vehicle
This article originally appeared on GOBankingRates.com: How To Get the Most Value From Your Costco Membership in 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development
MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces the appointment of Louise Peacock as Chief Regulatory and Quality Officer, based at the Company's Oxford, UK site. With more than 35 years in the pharmaceutical industry, Louise brings extensive and highly relevant experience to Aravax having previously made key contributions to the approval of Palforzia® - the first and only FDA approved oral immunotherapy (OIT) to treat peanut allergy. Louise has held prior roles as Chief Regulatory Affairs and Quality Officer at Vaderis Therapeutics AG and Alladapt Immunotherapeutics and was Head of Pharma R&D at Nestle Health Science/Aimmune Therapeutics (acquired by Nestle Health Science in 2020) where she had broad responsibilities for global regulatory affairs across pharma products in food allergy, gastrointestinal and metabolic disorders. Whilst at Aimmune, Louise was responsible for activities supporting the development and marketing approvals for Palforzia® in the US, EU, UK and Switzerland. Louise's early career included senior positions at Abbott Laboratories, Auxilium Pharmaceuticals, Intermune and Circassia. Louise received her BSc (Hons) Pharmacology from Kings College, London and her LLB (Hons) from the University of West London. Louise Peacock, Chief Regulatory and Quality Officer of Aravax, said, 'Despite recent advances, food allergy remains an ever-growing and life-threatening problem around the world and there is a critical need for better therapies. Having followed Aravax's developments, I am convinced that PVX108 has the potential to be a life-changing alternative for patients with peanut allergy. I look forward to joining what is a world-class team and to bringing my experience to bear on the rapid further development of PVX108 and other products.' Dr Pascal Hickey, CEO of Aravax, said, 'Louise's experience in regulatory affairs in the field of food allergy is unique. It spans all the major regulatory bodies and multiple programs including the successful approval of Palforzia®. We are enormously excited that she is joining the Aravax team.' About Aravax Aravax is a clinical stage biotechnology company focused on revolutionising the treatment of food allergies with next-generation, disease-modifying immunotherapies which are safer and more convenient than existing approaches. Aravax's proprietary platform generates engineered peptides that precisely retrain the immune system and restore the body's ability to safely tolerate food allergens, without putting patients at risk of treatment-induced acute allergic reactions, including anaphylaxis. The lead product, PVX108, is currently being studied in an international Phase 2 trial for the treatment of peanut allergy. Aravax is also developing a pipeline of products tackling additional significant food allergy indications. Aravax is an international company headquartered in Melbourne, Australia with a subsidiary in Oxford, UK and operations in USA and Europe. Aravax's investors include leading international and Australian investors including Novartis Venture Fund, Brandon Capital, Tenmile, Breakthrough Victoria, Uniseed and UniSuper. For more information visit: For further information please contact Media – AustraliaKirrily Davis, E: kdavis@ M: +61 (0)401 220228 Media - InternationalSue Charles, Charles Consultants E: M: +44 (0)7968 726585Chris Gardner, E: Chris@ M: +44 (0)7956 031077Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Upturn
30 minutes ago
- Business Upturn
CEOs of The LYCRA Company and Qore® Join Global Fashion Summit Lineup
Wilmington, Del., United States: The LYCRA Company, a global leader in developing sustainable fibers and solutions for the apparel industry, announced today that its CEO, Gary Smith, is a speaker at the Global Fashion Summit: Copenhagen Edition 2025. He will be joined on stage by Jon Veldhouse, CEO of Qore®, the maker of QIRA®, a next-generation BDO and a key ingredient in bio-derived LYCRA® fiber, which is launching later this year. This press release features multimedia. View the full release here: LYCRA® brand and QIRA® are principal sponsors of the Global Fashion Summit: Copenhagen Edition 2025. The brands are exhibiting at the event, where they will promote bio-derived LYCRA® fiber made with QIRA®, derived from field corn, to help make fashion more sustainable. Smith and Veldhouse will discuss the development of this sustainable fiber made from annually renewable field corn during their Fireside Chat: From Farm to Fashion. Their session takes place on Wednesday, June 4, at 3:35 CEST in the DR Concert Hall. The discussion will be moderated by Amy Nguyen, a researcher, writer, and founder of Sustainable & Social. This is the first time both companies are participating in the Global Fashion Summit, a premier platform focused on sustainability in the fashion industry. The companies have a prominent exhibit space for attendees to learn more about bio-derived LYCRA® fiber made with QIRA®. Here, visitors can be transported to the Qore® site and cornfields in Iowa through a virtual reality experience. Bio-derived LYCRA® EcoMade fiber will be the world's first large-scale, commercially available renewable elastane. It delivers equivalent performance to the original LYCRA® fiber and serves as a one-to-one replacement with no re-engineering of fabrics, processes, or garment patterns required. The product contains 70 percent renewable content and can potentially reduce the carbon footprint of LYCRA® fiber by up to 44 percent*. The LYCRA Company holds patents related to this renewable fiber in several regions including Europe. 'We're proud to join the Global Fashion Summit for the first time and showcase how collaboration can accelerate a more sustainable future for fashion,' said Gary Smith, CEO of The LYCRA Company. 'Partnering with Qore® has enabled us to scale innovation that is renewable and ready to meet the demands of global fashion brands striving to meet their sustainability goals.' The newly constructed Qore® site in Eddyville, Iowa, began operating last month and has started producing QIRA®. The company will host a grand opening celebration in July. 'Starting production at our new state-of-the-art facility marks a major step forward—not just for Qore®, but for the entire industry,' said Jon Veldhouse, CEO of Qore®. 'With QIRA® now being made in Iowa from annually renewable field corn, we're turning sustainable innovation into reality and helping our partners bring next-generation materials to market.' Learn more about this renewable offering by visiting *Estimate from Cradle-to-Gate Screening LCA for a representative LYCRA® fiber manufacturing facility, June 2022, prepared by Ramboll Americas Engineering Solutions, Inc. About The LYCRA Company The LYCRA Company is a leading global fiber and technology solutions provider to the apparel and personal care industries committed to offering sustainable products using renewable, pre-, and post-consumer recycled ingredients that reduce waste and help set the stage for circularity. Headquartered in Wilmington, Delaware, United States, it owns the LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL® brands. The LYCRA Company adds value to its customers' products by offering unique innovations that meet the consumer's need for comfort and lasting performance. Learn more at About Qore® LLC Formed through a joint venture by Cargill and HELM AG, Qore® helps leading brands replace fossil-based chemistries with bio-derived intermediates. At the heart of the joint venture is the production of QIRA®, the next-generation bio-derived 1,4-butanediol (BDO). Made biologically through the fermentation of plant-based sugars, QIRA® can save up to 86% of greenhouse gas emissions when replacing today's widely used chemical intermediates made from traditional fossil sources. Bio-derived QIRA® can be used the same way as its fossil counterpart but with significantly better environmental performance. For more information and inquiries, visit About The Global Fashion Summit Global Fashion Summit is a leading international forum for sustainability in fashion, presented by Global Fashion Agenda (GFA). Convening major decision makers from across the world, the forum was first launched in 2009 and has become a nexus for agenda-setting discussions and presentations on the most critical environmental, social and ethical issues facing our industry and planet, all intended to spark urgent action and accelerate impact in the industry. Learn more at LYCRA® is a trademark of The LYCRA Company. QIRA® is a trademark of Qore®. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.


Business Insider
an hour ago
- Business Insider
Analysts Are Neutral on Top Consumer Cyclical Stocks: Ulta Beauty (ULTA), Costco (COST)
Analysts fell to the sidelines weighing in on Ulta Beauty (ULTA – Research Report) and Costco (COST – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Confident Investing Starts Here: Ulta Beauty (ULTA) Barclays analyst Adrienne Yih maintained a Hold rating on Ulta Beauty on May 30 and set a price target of $485.00. The company's shares closed last Friday at $471.46. According to Yih is a 4-star analyst with an average return of 6.3% and a 49.0% success rate. Yih covers the NA sector, focusing on stocks such as National Vision Holdings, Dick's Sporting Goods, and Canada Goose Holdings. Ulta Beauty has an analyst consensus of Moderate Buy, with a price target consensus of $463.17, representing a -1.1% downside. In a report issued on May 15, Piper Sandler also maintained a Hold rating on the stock with a $386.00 price target. Costco (COST) Barclays analyst Seth Sigman maintained a Hold rating on Costco on May 30 and set a price target of $1000.00. The company's shares closed last Friday at $1040.18, close to its 52-week high of $1078.23. According to Sigman 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.3% and a 53.7% success rate. Sigman covers the NA sector, focusing on stocks such as Driven Brands Holdings, Floor & Decor Holdings, and Advance Auto Parts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Costco with a $1081.82 average price target, representing a 7.9% upside. In a report issued on May 29, Wells Fargo also maintained a Hold rating on the stock with a $1000.00 price target.